Potential application of dynamic contrast enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma
- PMID: 33459703
- DOI: 10.3233/CH-201085
Potential application of dynamic contrast enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma
Abstract
Objective: To investigate the clinical value of dynamic contrast enhanced ultrasound (D-CEUS) in predicting the microvascular invasion (MVI) of hepatocellular carcinoma (HCC).
Patients and methods: In this retrospective study, 16 patients with surgery and histopathologically proved HCC lesions were included. Patients were classified according to the presence of MVI: MVI positive group (n = 6) and MVI negative group (n = 10). Contrast enhanced ultrasound (CEUS) examinations were performed within a week before surgery. Dynamic analysis was performed by VueBox® software (Bracco, Italy). Three regions of interests (ROIs) were set in the center of HCC lesions, at the margin of HCC lesions and in the surrounding liver parenchyma accordingly. Time intensity curves (TICs) were generated and quantitative perfusion parameters including WiR (wash-in rate), WoR (wash-out rate), WiAUC (wash-in area under the curve), WoAUC (wash-out area under the curve) and WiPi (wash-in perfusion index) were obtained and analyzed.
Results: All of HCC lesions showed arterial hyperenhancement (100 %) and at the late phase as hypoenhancement (75%) in CEUS. Among all CEUS quantitative parameters, the WiAUC and WoAUC were higher in MVI positive group than in MVI negative group in the center HCC lesions (P < 0.05), WiAUC, WoAUC and WiPI were higher in MVI positive group than in MVI negative group at the margin of HCC lesions. WiR and WoR were significant higher in MVI positive group.
Conclusions: D-CEUS with quantitative perfusion analysis has potential clinical value in predicting the existence of MVI in HCC lesions.
Keywords: Dynamic contrast enhanced ultrasound (D-CEUS); hepatocellular carcinoma (HCC); microvascular invasion (MVI); prediction; time intensity curves (TICs).
Similar articles
-
Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver.Ultrasound Med Biol. 2023 Aug;49(8):1780-1788. doi: 10.1016/j.ultrasmedbio.2023.03.026. Epub 2023 May 6. Ultrasound Med Biol. 2023. PMID: 37156676
-
VueBox® perfusion analysis of dynamic contrast enhanced ultrasound provides added value in the diagnosis of small thyroid nodules.Clin Hemorheol Microcirc. 2023;83(4):409-420. doi: 10.3233/CH-221681. Clin Hemorheol Microcirc. 2023. PMID: 36683500
-
Study on correlation between two-dimensional ultrasound, contrast-enhanced ultrasound and microvascular invasion in hepatocellular carcinoma.Clin Hemorheol Microcirc. 2022;80(2):97-106. doi: 10.3233/CH-211190. Clin Hemorheol Microcirc. 2022. PMID: 34057142
-
Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma.J Gastroenterol Hepatol. 2018 Feb;33(2):347-354. doi: 10.1111/jgh.13843. J Gastroenterol Hepatol. 2018. PMID: 28589639 Review.
-
Contrast-enhanced ultrasound demonstrates greater adjuvant potential: past, current status, and future applications in Hepatocellular carcinoma early diagnosis.Med Ultrason. 2023 Sep 29;25(3):304-311. doi: 10.11152/mu-3949. Epub 2023 Mar 11. Med Ultrason. 2023. PMID: 36996383 Review.
Cited by
-
Early Assessment of Chemoradiotherapy Response for Locally Advanced Pancreatic Ductal Adenocarcinoma by Dynamic Contrast-Enhanced Ultrasound.Diagnostics (Basel). 2022 Nov 2;12(11):2662. doi: 10.3390/diagnostics12112662. Diagnostics (Basel). 2022. PMID: 36359506 Free PMC article.
-
Quantitative analysis of pre-treatment dynamic contrast-enhanced ultrasound for assessing the response of colorectal liver metastases to chemotherapy plus targeted therapy: a dual-institutional study.Abdom Radiol (NY). 2024 Feb;49(2):414-424. doi: 10.1007/s00261-023-04055-0. Epub 2023 Oct 18. Abdom Radiol (NY). 2024. PMID: 37853236
-
The diagnostic value of contrast-enhanced ultrasound for cervical tuberculous lymphadenitis.Clin Hemorheol Microcirc. 2022;81(1):69-79. doi: 10.3233/CH-211355. Clin Hemorheol Microcirc. 2022. PMID: 35001882 Free PMC article.
-
Analysis of Sonazoid contrast-enhanced ultrasound for predicting the risk of microvascular invasion in hepatocellular carcinoma: a prospective multicenter study.Eur Radiol. 2023 Oct;33(10):7066-7076. doi: 10.1007/s00330-023-09656-3. Epub 2023 Apr 28. Eur Radiol. 2023. PMID: 37115213
-
Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis.Diagnostics (Basel). 2023 Jan 9;13(2):238. doi: 10.3390/diagnostics13020238. Diagnostics (Basel). 2023. PMID: 36673048 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical